Christopher Bishop Behavioral Neuroscience Program, Department of Psychology Binghamton University Biography Publications Institution JoVE Articles Christopher Bishop has not added a biography. If you are Christopher Bishop and would like to personalize this page please email our Author Liaison for assistance. Publications Combined Knockout of Lrrk2 and Rab29 Does Not Result in Behavioral Abnormalities in Vivo Journal of Parkinson's Disease. Jan, 2021 | Pubmed ID: 33523017 Effects of Pedunculopontine Nucleus Cholinergic Lesion on Gait and Dyskinesia in Hemiparkinsonian Rats The European Journal of Neuroscience. Jan, 2021 | Pubmed ID: 33426708 Genetic Suppression of the Dopamine D3 Receptor in Striatal D1 Cells Reduces the Development of L-DOPA-induced Dyskinesia Experimental Neurology. Feb, 2021 | Pubmed ID: 33249031 Dopamine Receptor Cooperativity Synergistically Drives Dyskinesia, Motor Behavior, and Striatal GABA Neurotransmission in Hemiparkinsonian Rats Neuropharmacology. 09, 2020 | Pubmed ID: 32492451 Striatal Nurr1, but Not FosB Expression Links a Levodopa-induced Dyskinesia Phenotype to Genotype in Fisher 344 Vs. Lewis Hemiparkinsonian Rats Experimental Neurology. 08, 2020 | Pubmed ID: 32387398 Reciprocal Cross-sensitization of D1 and D3 Receptors Following Pharmacological Stimulation in the Hemiparkinsonian Rat Psychopharmacology. Jan, 2020 | Pubmed ID: 31435690 Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease Frontiers in Pharmacology. 2019 | Pubmed ID: 32009944 Neuroinflammation: Fanning the Fire of L-dopa-induced Dyskinesia Movement Disorders : Official Journal of the Movement Disorder Society. 12, 2019 | Pubmed ID: 31845761 Late Aging-associated Increases in L-DOPA-induced Dyskinesia Are accompanied by Heightened Neuroinflammation in the Hemi-parkinsonian Rat Neurobiology of Aging. 09, 2019 | Pubmed ID: 31306813 Effects of Muscarinic Acetylcholine M1 and M4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat Neuroscience. 06, 2019 | Pubmed ID: 31029732 Biased G Protein-Independent Signaling of Dopamine D-D Receptor Heteromers in the Nucleus Accumbens Molecular Neurobiology. Oct, 2019 | Pubmed ID: 30919214 Regulation of Dopamine Neurotransmission from Serotonergic Neurons by Ectopic Expression of the Dopamine D2 Autoreceptor Blocks Levodopa-induced Dyskinesia Acta Neuropathologica Communications. 01, 2019 | Pubmed ID: 30646956 Diverse Serotonin Actions of Vilazodone Reduce L-3,4-dihidroxyphenylalanine-induced Dyskinesia in Hemi-parkinsonian Rats Movement Disorders : Official Journal of the Movement Disorder Society. 11, 2018 | Pubmed ID: 30485908 Behavioral and Cellular Dopamine D and D Receptor-mediated Synergy: Implications for L-DOPA-induced Dyskinesia Neuropharmacology. 08, 2018 | Pubmed ID: 29936243 A New Outlook on Cholinergic Interneurons in Parkinson's Disease and L-DOPA-induced Dyskinesia Neuroscience and Biobehavioral Reviews. 09, 2018 | Pubmed ID: 29782883 Striatal Norepinephrine Efflux in L-DOPA-induced Dyskinesia Neurochemistry International. 03, 2018 | Pubmed ID: 29371053 Serotonergic Targets for the Treatment of L-DOPA-induced Dyskinesia Journal of Neural Transmission (Vienna, Austria : 1996). 08, 2018 | Pubmed ID: 29305656 D-512, a Novel Dopamine D Receptor Agonist, Demonstrates Greater Anti-Parkinsonian Efficacy Than Ropinirole in Parkinsonian Rats British Journal of Pharmacology. Sep, 2017 | Pubmed ID: 28667675 Ceftriaxone Reduces L-dopa-induced Dyskinesia Severity in 6-hydroxydopamine Parkinson's Disease Model Movement Disorders : Official Journal of the Movement Disorder Society. Nov, 2017 | Pubmed ID: 28631864 Characterizing the Differential Roles of Striatal 5-HT Auto- and Hetero-receptors in the Reduction of L-DOPA-induced Dyskinesia Experimental Neurology. 06, 2017 | Pubmed ID: 28342749 The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in L-DOPA-Induced Dyskinesia in Parkinsonian Rats The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 09, 2016 | Pubmed ID: 27656025 Monoamine Transporter Contributions to L-DOPA Effects in Hemi-parkinsonian Rats Neuropharmacology. 11, 2016 | Pubmed ID: 27452719 A Working Model for the Assessment of Disruptions in Social Behavior Among Aged Rats: The Role of Sex Differences, Social Recognition, and Sensorimotor Processes Experimental Gerontology. Apr, 2016 | Pubmed ID: 26811912 Effect of Tricyclic Antidepressants on L-DOPA-induced Dyskinesia and Motor Improvement in Hemi-parkinsonian Rats Pharmacology, Biochemistry, and Behavior. Mar, 2016 | Pubmed ID: 26791104 Alterations in Primary Motor Cortex Neurotransmission and Gene Expression in Hemi-parkinsonian Rats with Drug-induced Dyskinesia Neuroscience. Dec, 2015 | Pubmed ID: 26363150 Effects of the Beta-adrenergic Receptor Antagonist Propranolol on Dyskinesia and L-DOPA-induced Striatal DA Efflux in the Hemi-parkinsonian Rat Journal of Neurochemistry. Jul, 2015 | Pubmed ID: 25866285 Modulation of L-DOPA's Antiparkinsonian and Dyskinetic Effects by α2-noradrenergic Receptors Within the Locus Coeruleus Neuropharmacology. Aug, 2015 | Pubmed ID: 25817388 Effects of Noradrenergic Denervation by Anti-DBH-saporin on Behavioral Responsivity to L-DOPA in the Hemi-parkinsonian Rat Behavioural Brain Research. Aug, 2014 | Pubmed ID: 24837745 Effects of Prolonged Selective Serotonin Reuptake Inhibition on the Development and Expression of L-DOPA-induced Dyskinesia in Hemi-parkinsonian Rats Neuropharmacology. Feb, 2014 | Pubmed ID: 24067924 Critical Involvement of the Motor Cortex in the Pathophysiology and Treatment of Parkinson's Disease Neuroscience and Biobehavioral Reviews. Dec, 2013 | Pubmed ID: 24113323 Effects of 5-HT1A Receptor Stimulation on Striatal and Cortical M1 PERK Induction by L-DOPA and a D1 Receptor Agonist in a Rat Model of Parkinson's Disease Brain Research. Nov, 2013 | Pubmed ID: 24060645 The Impact of Ventral Noradrenergic Bundle Lesions on Increased IL-1 in the PVN and Hormonal Responses to Stress in Male Sprague Dawley Rats Endocrinology. Jul, 2013 | Pubmed ID: 23671261 Effects of 5-HT1A Receptor Stimulation on D1 Receptor Agonist-induced Striatonigral Activity and Dyskinesia in Hemiparkinsonian Rats ACS Chemical Neuroscience. May, 2013 | Pubmed ID: 23496922 The Effects of BMY-14802 Against L-DOPA- and Dopamine Agonist-induced Dyskinesia in the Hemiparkinsonian Rat Psychopharmacology. Jun, 2013 | Pubmed ID: 23389756 Serotonin Transporter Inhibition Attenuates L-DOPA-induced Dyskinesia Without Compromising L-DOPA Efficacy in Hemi-parkinsonian Rats The European Journal of Neuroscience. Sep, 2012 | Pubmed ID: 22762478 Effects of Noradrenergic Denervation on L-DOPA-induced Dyskinesia and Its Treatment by α- and β-adrenergic Receptor Antagonists in Hemiparkinsonian Rats Pharmacology, Biochemistry, and Behavior. Jan, 2012 | Pubmed ID: 21978941 Enhancement of the Hypothalamic-pituitary-adrenal Axis but Not Cytokine Responses to Stress Challenges Imposed During Withdrawal from Acute Alcohol Exposure in Sprague-Dawley Rats Psychopharmacology. Nov, 2011 | Pubmed ID: 21735074 Role of the Primary Motor Cortex in L-Dopa-induced Dyskinesia and Its Modulation by 5-HT1A Receptor Stimulation Neuropharmacology. Sep, 2011 | Pubmed ID: 21635907 Behavioral and Cellular Modulation of L-DOPA-induced Dyskinesia by Beta-adrenoceptor Blockade in the 6-hydroxydopamine-lesioned Rat The Journal of Pharmacology and Experimental Therapeutics. Jun, 2011 | Pubmed ID: 21402691 Local Modulation of Striatal Glutamate Efflux by Serotonin 1A Receptor Stimulation in Dyskinetic, Hemiparkinsonian Rats Experimental Neurology. Jun, 2011 | Pubmed ID: 21352823 Serotonin 1B Receptor Stimulation Reduces D1 Receptor Agonist-induced Dyskinesia Neuroreport. Sep, 2009 | Pubmed ID: 19633584 Contribution of the Striatum to the Effects of 5-HT1A Receptor Stimulation in L-DOPA-treated Hemiparkinsonian Rats Journal of Neuroscience Research. May, 2009 | Pubmed ID: 19115412 MDMA and Fenfluramine Reduce L-DOPA-induced Dyskinesia Via Indirect 5-HT1A Receptor Stimulation The European Journal of Neuroscience. May, 2006 | Pubmed ID: 16817869 Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease Natalie Landeck1, Melissa Conti Mazza1, Megan Duffy1, Christopher Bishop2, Caryl E. Sortwell3, Mark R. Cookson1 1Cell Biology and Gene Expression Section, National Institute on Aging, National Institutes of Health, 2Behavioral Neuroscience Program, Department of Psychology, Binghamton University, 3Department of Translational Neuroscience, Mercy Health Hauenstein Neuroscience Medical Center, Michigan State University JoVE 62128 Neuroscience
Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease Natalie Landeck1, Melissa Conti Mazza1, Megan Duffy1, Christopher Bishop2, Caryl E. Sortwell3, Mark R. Cookson1 1Cell Biology and Gene Expression Section, National Institute on Aging, National Institutes of Health, 2Behavioral Neuroscience Program, Department of Psychology, Binghamton University, 3Department of Translational Neuroscience, Mercy Health Hauenstein Neuroscience Medical Center, Michigan State University JoVE 62128 Neuroscience